Mr. Jeff Ciachurski reports
CAPTIVA VERDE COMPLETES ACQUISITION OF A FULL AUTHORITY TO IMPORT, MARKET AND DISTRIBUTE ALL CANNABIS PRODUCTS IN MEXICO
Captiva Verde Land Corp., further to its news release of Jan. 10, 2019, has executed and completed a share exchange agreement with Salud Esmeralda de Mexico SA de CV for the exchange of all of the shares of Esmeralda for 80 million common shares of Captiva. The shares are subject to a pooling agreement for one year.
Esmeralda and its team and advisers have over 200 years of experience in high-level executive positions in Mexico, including energy, health, natural resources, government, business and the military.
Prior to this announcement, Esmeralda and its principals acquired, from another Mexican corporation, a comprehensive pharmaceutical licence to sell, market and distribute the entire suite of pharmaceutical, health, wellness and veterinarian products which include all psychoactive and non-psychoactive drugs listed under groups I, II and III. These include a suite of over 300 medicines.
Captiva's sole mission is to provide all of Mexico with the highest-quality medical products, including cannabis products, that are sourced from the best suppliers that have the highest proven efficacy all at the lowest possible prices to the Mexican consumer. In addition, Captiva Verde will ensure that all Cannabis products and other medical products meet the tough standards of the Mexican health authorities.
Captiva management will dedicate the next several months to informing the cannabis market and the general financial markets of the significance of this game-changing licence to import, wholesale and distribute.
We seek Safe Harbor.
© 2020 Canjex Publishing Ltd. All rights reserved.